Generer rapport
Jørgen Kruuse A/S
Havretoften 4, Langeskov, 5550 Langeskov, CVR 35243216
Virksomhedsform
Aktieselskab
Etableret
1939
Størrelse
Mellemstore
Ansatte
172
Omsætning
512
MDKK
Bruttofortj.
154
MDKK
Primært resultat (EBIT)
31
MDKK
Årets resultat
39
MDKK
Egenkapital
249
MDKK
annonce
Flere nøgletal og analyser?
Med en Bisbase Premium konto får du flere nøgletal for både virksomheder, koncerner og brancher samt adgang til eksklusive brancher indeholdende virksomheder nøje sammensat af eksperter. Og vil du lave dine egne analyser kan du også det! Det tager få minutter at få adgang - og det behøver ikke at koste dig noget!
Rang Årets resultat
Rang i branche
6/292
"Top 10%"
Rang i Danmark
3.833/342.443
"Top 10%"
Direktion top 3
Tino Bendix 4 | CEO |
Mads Bonne Alkærsig 4 | Direktør |
Bestyrelse top 3
Graham Michael Rhodes 3 | Bestyrelsesformand |
Tino Bendix 4 | Bestyrelsesmedlem |
Gitte Rene Uhrenholt 1 | Bestyrelsesmedlem |
Legale ejere top 3
100% | Projectsilver Aps | DK |
Tegningsregler
Selskabet tegnes af bestyrelsesformanden i forening med et andet bestyrelsesmedlem eller af bestyrelsesformanden i forening med en direktør eller af den samlede bestyrelse.
Stamoplysninger baseret på CVR
Navn | Jørgen Kruuse A/S |
Binavne | Pet Partner A/S, Scanpet A/S Vis mere |
CVR | 35243216 |
Adresse | Havretoften 4, Langeskov, 5550 Langeskov |
Branche | Engroshandel med læge- og hospitalsartikler [464620] |
Etableret | 02-05-1939 (84 år) |
Virksomhedsform | Aktieselskab |
Antal ansatte | 153 (årsværk:137) |
Reklamebeskyttelse | Nej |
Revisor | Bdo Statsautoriseret Revisionsaktieselskab siden 27-11-1998 |
Regnskabsperiode | 01-01 til 31-12 |
Bankforbindelse | Nordea Bank |
Selskabskapital | 1.000.000 DKK |
Vedtægter seneste | 23-12-2015 |
Medlem af brancherne
- Engroshandel med læge- og hospitalsartiklerNACE6 indeholdende 376 virk.
- Engroshandel med husholdningsartiklerNACE3 indeholdende 6.348 virk.
- Engroshandel undtagen med motorkøretøjer og motorcyklerNACE2 indeholdende 24.387 virk.
- Engroshandel og detailhandel, reparation af motorkøretøjer og motorcyklerNACE1 indeholdende 75.353 virk.
Formål
Selskabets formål er direkte og indirekte at drive fabrikations- og handelsvirksomhed samt anden i forbindelse hermed stående virksomhed. The objective of the Company is, directly and indirectly, to carry on the business of manufacturing and trading as well as other ancillary business.
Regnskab
2022 | 2021 | 2020 | |
---|---|---|---|
Valuta/enhed | 000' DKK | 000' DKK | 000' DKK |
Omsætning | 512.499 -17% | 617.608 +16% | 530.476 +2% |
Bruttofortjeneste | 154.460 -26% | 208.458 +18% | 177.033 +28% |
Årets resultat | 38.545 -58% | 91.281 +43% | 63.859 +81% |
Egenkapital | 249.305 -14% | 289.632 +1% | 287.933 +28% |
Balance | 376.557 -18% | 457.219 +4% | 438.408 -20% |
Ledelsesberetning
Development in activities and financesThe company's income statement shows a profit before tax of DKK 45.48 m, a decrease of DKK 65.83 m / 59.14% against 2021. The balance sheet on 31 December 2022 shows an equity amount of DKK 249.31 m and a balance sheet total of DKK 376.56 m. During the year, the Swedish company Next2vet AB, has been acquired to increase the market share on the Swedish market. For more information see section “Profit/loss for the year in relation to expected developments”.
Particular risks
The company’s most significant operating risk is attached to the ability to be strongly positioned in the markets where its products are sold and to currently ensure high service and quality at competitive prices. The goal is to maintain a strong market position, ensure high service quality and competitive prices. In order to strengthen the continued strong market position, service, quality and competitive prices processes are in place in all areas to proactively prevent and minimize risks.
Policies are in place to ensure existing and potential material risks that could impact the achievement of strategic objectives are identified, managed or mitigated.
Foreign exchange risks:
The company's revenue and earnings are related to the development for SEK, NOK, GBP, and USD. No speculative foreign currency positions are made. To avoid unnecessary currency risk, all bank accounts are exchanged to local currency every month.
Exchange adjustments of investments in subsidiary enterprises, which are independent entities, are recognized directly in the equity. Related exchange risks are generally not hedged because it is the company’s opinion that a current hedging of such long‑term investments will not be optimal from an overall risk and cost viewpoint.
Interest rate risk:
The short‑term debt is subject to a variable interest rate. Changes in interest rates will therefore influence earnings.
Particular risks
The company’s most significant operating risk is attached to the ability to be strongly positioned in the markets where its products are sold and to currently ensure high service and quality at competitive prices. The goal is to maintain a strong market position, ensure high service quality and competitive prices. In order to strengthen the continued strong market position, service, quality and competitive prices processes are in place in all areas to proactively prevent and minimize risks.
Policies are in place to ensure existing and potential material risks that could impact the achievement of strategic objectives are identified, managed or mitigated.
Foreign exchange risks:
The company's revenue and earnings are related to the development for SEK, NOK, GBP, and USD. No speculative foreign currency positions are made. To avoid unnecessary currency risk, all bank accounts are exchanged to local currency every month.
Exchange adjustments of investments in subsidiary enterprises, which are independent entities, are recognized directly in the equity. Related exchange risks are generally not hedged because it is the company’s opinion that a current hedging of such long‑term investments will not be optimal from an overall risk and cost viewpoint.
Interest rate risk:
The short‑term debt is subject to a variable interest rate. Changes in interest rates will therefore influence earnings.
30-06-2023